Aa Phase 2 clinical trial compared what happened in people with major depressive disorder after taking a 25 mg dose of psilocybin versus niacin, a placebo.
Aa Phase 2 clinical trial compared what happened in people with major depressive disorder after taking a 25 mg dose of psilocybin versus niacin, a placebo.